A paper by Kei Sato’s group (Division of Systems Immunology) was published in EMBO Reports.

ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS

Müller M, Herrmann A, Fujita S, Uriu K, Kruth C, Strange A, Kolberg JE, Schneider M, Ito J, Müller MA, Drosten C, Ensser A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K, Sauter D.